Clinical Trials Browser

Phase 1/2 × INDUSTRY × Meningeal Carcinomatosis × Clear all

NCT04315246 2022-07-15

177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)

Phase 1/2 Withdrawn

Meningeal Carcinomatosis